Cargando…

Human scent as a first-line defense against disease

Individuals may have a different body odor, when they are sick compared to healthy. In the non-human animal literature, olfactory cues have been shown to predict avoidance of sick individuals. We tested whether the mere experimental activation of the innate immune system in healthy human individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Amy R., Lundström, Johan N., Kimball, Bruce A., Karshikoff, Bianka, Sorjonen, Kimmo, Axelsson, John, Lekander, Mats, Olsson, Mats J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550911/
https://www.ncbi.nlm.nih.gov/pubmed/37794120
http://dx.doi.org/10.1038/s41598-023-43145-3
_version_ 1785115649402470400
author Gordon, Amy R.
Lundström, Johan N.
Kimball, Bruce A.
Karshikoff, Bianka
Sorjonen, Kimmo
Axelsson, John
Lekander, Mats
Olsson, Mats J.
author_facet Gordon, Amy R.
Lundström, Johan N.
Kimball, Bruce A.
Karshikoff, Bianka
Sorjonen, Kimmo
Axelsson, John
Lekander, Mats
Olsson, Mats J.
author_sort Gordon, Amy R.
collection PubMed
description Individuals may have a different body odor, when they are sick compared to healthy. In the non-human animal literature, olfactory cues have been shown to predict avoidance of sick individuals. We tested whether the mere experimental activation of the innate immune system in healthy human individuals can make an individuals’ body odor be perceived as more aversive (intense, unpleasant, and disgusting). Following an endotoxin injection (lipopolysaccharide; 0.6 ng/kg) that creates a transient systemic inflammation, individuals smelled more unpleasant compared to a placebo group (saline injection). Behavioral and chemical analyses of the body odor samples suggest that the volatile components of samples from “sick” individuals changed qualitatively rather than quantitatively. Our findings support the hypothesis that odor cues of inflammation in axillary sweat are detectable just a few hours after experimental activation of the innate immune system. As such, they may trigger behavioral avoidance, hence constituting a first line of defense against pathogens of infected conspecifics.
format Online
Article
Text
id pubmed-10550911
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105509112023-10-06 Human scent as a first-line defense against disease Gordon, Amy R. Lundström, Johan N. Kimball, Bruce A. Karshikoff, Bianka Sorjonen, Kimmo Axelsson, John Lekander, Mats Olsson, Mats J. Sci Rep Article Individuals may have a different body odor, when they are sick compared to healthy. In the non-human animal literature, olfactory cues have been shown to predict avoidance of sick individuals. We tested whether the mere experimental activation of the innate immune system in healthy human individuals can make an individuals’ body odor be perceived as more aversive (intense, unpleasant, and disgusting). Following an endotoxin injection (lipopolysaccharide; 0.6 ng/kg) that creates a transient systemic inflammation, individuals smelled more unpleasant compared to a placebo group (saline injection). Behavioral and chemical analyses of the body odor samples suggest that the volatile components of samples from “sick” individuals changed qualitatively rather than quantitatively. Our findings support the hypothesis that odor cues of inflammation in axillary sweat are detectable just a few hours after experimental activation of the innate immune system. As such, they may trigger behavioral avoidance, hence constituting a first line of defense against pathogens of infected conspecifics. Nature Publishing Group UK 2023-10-04 /pmc/articles/PMC10550911/ /pubmed/37794120 http://dx.doi.org/10.1038/s41598-023-43145-3 Text en © Crown 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Gordon, Amy R.
Lundström, Johan N.
Kimball, Bruce A.
Karshikoff, Bianka
Sorjonen, Kimmo
Axelsson, John
Lekander, Mats
Olsson, Mats J.
Human scent as a first-line defense against disease
title Human scent as a first-line defense against disease
title_full Human scent as a first-line defense against disease
title_fullStr Human scent as a first-line defense against disease
title_full_unstemmed Human scent as a first-line defense against disease
title_short Human scent as a first-line defense against disease
title_sort human scent as a first-line defense against disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550911/
https://www.ncbi.nlm.nih.gov/pubmed/37794120
http://dx.doi.org/10.1038/s41598-023-43145-3
work_keys_str_mv AT gordonamyr humanscentasafirstlinedefenseagainstdisease
AT lundstromjohann humanscentasafirstlinedefenseagainstdisease
AT kimballbrucea humanscentasafirstlinedefenseagainstdisease
AT karshikoffbianka humanscentasafirstlinedefenseagainstdisease
AT sorjonenkimmo humanscentasafirstlinedefenseagainstdisease
AT axelssonjohn humanscentasafirstlinedefenseagainstdisease
AT lekandermats humanscentasafirstlinedefenseagainstdisease
AT olssonmatsj humanscentasafirstlinedefenseagainstdisease